Amylin Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Amylin Pharmaceuticals Ownership

Who owns Amylin Pharmaceuticals?

Amylin Pharmaceuticals is owned by Bristol-Myers Squibb. It was acquired on June 29, 2012.

Amylin Pharmaceuticals Business Overview

Where is Amylin Pharmaceuticals headquartered?

Amylin Pharmaceuticals is headquartered in San Diego, California.

How many employees does Amylin Pharmaceuticals have?

Amylin Pharmaceuticals has 1,300 employees.

What sector is Amylin Pharmaceuticals in?

Amylin Pharmaceuticals is a life science company.

When was Amylin Pharmaceuticals founded?

Amylin Pharmaceuticals was founded in 1987.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Subscribe to Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

Acquired by Bristol-Myers Squibb Co. (Company) on 2012-06-29

Amylin Pharmaceuticals LLC

9360 Towne Centre Drive,
San Diego, California 92121
United States,
(858)552-2200
www.amylin.com

Amylin Pharmaceuticals, Inc. is a biopharmaceutical company developing drugs for the treatment of diabetes, obesity, and cardiovascular disease.

Company Summary

SECTOR

Revenue

650	2011
(millions of USD)

Employees

1,300

Established

1987

Subsidiary of

Bristol-Myers Squibb

Investor History
2012-06-29
Add-on Acquisition

5.3B USD

Bristol-Myers Squibb

Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

Unlimited Searches
Unlimited Profile Views
Build and Export Lists of

PE Backed Companies
Direct Investors & Acquirers
Advisors
Deals
& More

Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

Stay informed on events in your industry
M&A research that takes seconds (not all afternoon)
Better understand your customers and prospects
Discover active buyers (or sellers)

Search

4.7K Private Equity Firms
208K M&A Transactions
210K Companies Involved in M&A
(Buyer, Seller, or Target)
3.7K M&A Advisors
(Investment Banks and Law Firms)
81K M&A Contacts
(PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Amylin Pharmaceuticals

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies